Some companies offered exactly what people needed after the coronavirus hit, but once the pandemic is under control, will you still want them in your portfolio?
News & Analysis: Clorox
Investors in their golden years should seek a balance of reliability, yield, and payout growth.
CLX earnings call for the period ending December 31, 2020.
Clorox's future success may not be able to replicate the strong performance seen in 2020.
The smaller company is not only more agile, but it's got a clear, plausible plan of action to grow sales and widen margins.
Clorox and two other consumer staples giants are still resilient investments for an uncertain market.
Wall Street's estimates for sales growth could "prove conservative."
This dividend stock should continue to grow revenue and earnings even after the COVID-19 pandemic.
The consumer goods giant may never again see sales growth like it saw earlier this year, but it's still well-prepared for the future.
The consumer goods veteran starts its new fiscal year with a bang.